Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Treatment and Management of Cancer in the Frail Elderly
1
x
$
0.00
Psiquiatría de enlace: Tiroides y enfermedades del ánimo
1
x
$
0.00
Oncology Ethics: Forum The Expanding Indications for Preimplantation Genetic Diagnosis
1
x
$
0.00
Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?
1
x
$
30.00
Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study
1
x
$
30.00
Paroxetine Treatment of Depression in Late Life
1
x
$
30.00
Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-Resistant Schizophrenia
1
x
$
30.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 1
1
x
$
15.00
Jun-Sheng Wang, MD, PhD: Pharmacokinetics and Drug Interactions of the Sedative Hypnotics
1
x
$
30.00
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
1
x
$
30.00
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
1
x
$
30.00
Paroxetine Treatment of Generalized Anxiety Disorder
1
x
$
30.00
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
1
x
$
30.00
View Cart
Checkout
Home
Store
“A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Valproate Use in Neuropsychiatric Disorders in the Elderly
$
30.00
Add to cart
Details
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
The Use of Divalproex in the Treatment of Addictive Disorders
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
Divalproex in the Treatment of Bipolar Disorder
$
30.00
Add to cart
Details
The Efficacy of Divalproex for Partial Epilepsies
$
30.00
Add to cart
Details
Divalproex and Epilepsy
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
$
30.00
Add to cart
Details
Clinical Management of Perinatal Depression: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
$
30.00
Add to cart
Details
Paroxetine Treatment of Depression in Late Life
$
30.00
Add to cart
Details
Paroxetine Use in Medically Ill Patients
$
30.00
Add to cart
Details
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
$
30.00
Add to cart
Details
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Treatment of Panic Disorder: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Previous
1
…
40
41
42
…
44
Next
Page load link
Go to Top
